Article Information
History
- November 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Axel AS Laurell1,2,*,
- Ashwin V Venkataraman3,4,5,*,
- Tatjana Schmidt6,
- Marcella Montagnese6,
- Christoph Mueller3,5,
- Robert Stewart3,5,
- Jonathan Lewis2,
- Clare Mundell2,
- Jeremy D Isaacs7,8,
- Mani S Krishnan9,
- Robert Barber10,
- Timothy Rittman6 and
- Benjamin R Underwood1,2,†
- 1Department of Psychiatry, University of Cambridge, Cambridge, UK
- 2Cambridgeshire and Peterborough NHS Foundation Trust, UK
- 3Department of Old Age Psychiatry, IoPPN, King’s College London, London, UK
- 4Centre for Neuroimaging Sciences, IoPPN, King’s College London, London, UK
- 5South London and Maudsley NHS Foundation Trust, London, UK
- 6Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- 7Department of Neurology, Atkinson Morley Regional Neuroscience Centre, St George’s University Hospitals NHS Foundation Trust, London
- 8Molecular and Clinical Sciences Research Institute, St George’s, University of London, London
- 9Tees, Esk and Wear Valleys NHS Foundation Trust, UK
- 10Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK
- ↵†Corresponding author
ben.underwood{at}cpft.nhs.uk
↵* The authors contributed equally to this paper.
Posted November 17, 2023.
Estimating Demand for Potential Disease modifying Therapies for Alzheimer’s Disease in the UK
